Reuters -- U.S. health regulators have cautioned Australia’s CSL Ltd after uncovering problems at its influenza vaccine manufacturing plant and want to meet with company officials, according to a letter released on Monday.
Reuters -- U.S. health regulators have cautioned Australia’s CSL Ltd after uncovering problems at its influenza vaccine manufacturing plant and want to meet with company officials, according to a letter released on Monday.
